• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Derivatives of D-2-hydroxy-4- methylmercaptobutyric acid of the formula <IMAGE> wherein A represents sodium, potassium or one equivalent of magnesium or calcium or a methyl group and R represents hydrogen or an acetyl group; are useful in fodder, as a food or as a medicine where they may act as methionine supplements. They may be prepared by treating D- methionine with nitrous acid and reacting the D-2-hydroxy-4- methylbutyric acid formed with an oxide, hydroxide, carbonate or bicarbonate of the appropriate metal to form the salt or with methanol to form the ester and/or an acetylating compound to form the acetylated product. The calcium salt of D-2- hydroxy-4-methylmercaptobutyric acid is particularly useful in pharmaceutical preparations for patients having renal insufficiencies.
    公开号:SU895286A3
    申请号:SU792847562
    申请日:1979-11-30
    公开日:1981-12-30
    发明作者:Х.Бакер Давид；Фаненштих Рудольф；Клееманн Аксель；Леманн Бернд；Мартенс Юрген；Таннер Херберт
    申请人:Дегусса Аг (Фирма)；
    IPC主号:
    专利说明:

    the action of the corresponding L-form o-hydroxy-amino acid. The derivatives of D-2-hydroxy-4-methylmer capto-butyric acid corresponding to the proposed method with regard to physiological nutritional effects are more effective than the corresponding racemates, i.e. mixtures consisting of 10% of the ZE Form and 50% of the L-form. As a consequence, and in the case of these 2-hydroxy-4-methyl derivatives, the corresponding 35-forms) we must be incomparably more effective in comparison with similar li-forms. In the manufacture of the proposed method of derivatives, it is necessary to first obtain a pure with respect to the enantiomers of 1) -2-hydroxy-4-methyl-merciptomacy acid. You can do this as follows. P-Methionine, taken in 0.25-5 times, preferably 0.6-1 times against molar amounts, is dissolved or suspended in a solution of sulfuric acid at a concentration of 5-5 O% by weight, preferably 1 O-20 weight .%. At a temperature in the range of -5 to 50 ° C, preferably in the range of O-5 ° C in the course of 1-18 hours, preferably 1-3 hours, then shift with an aqueous solution of sodium nitrite, taken in the amount of 0.5- 5 mol, preferably 1-1.4 mol per 1 mop of the D-methionic used. Then the reaction mixture is left to stand to complete the subsequent reaction for 5-24 hours, preferably 12 hours at 20-50 ° C, preferably 20-25 ° C. Next, the solution is saturated with sodium chloride and extracted with an inert organic solvent that is not displaced with water. . After evaporation of the solvent from the extract, the crude purity of D-2-hydroxy-4-methyl mercaptoacetic acid is obtained as an oily product. This product can be converted directly to the corresponding derivative. according to the degree of purity 1) -2-approx. Raw, according to the degree of purity JJ-OKsi-4-methyl mercaptoacid, it is preferable to purify them before obtaining the corresponding derivative. This operation is expediently carried out by exchange with an amine with a chain to produce an ammonium salt, which is usually easier to clean. A particularly favorable reaction is the exchange with cyclohexylamine, since the dicyclohexipammonium salt can be very easily purified by recrystallization, for example, from a mixture of ethyl acetate and petroleum ether. From the purified ammonium salt, the pure 1) -2-hydroxy-4-methyl-mercaptobutyric acid is again released by the addition of a strong acid, for example a 40% aqueous solution of sulfuric acid, and finally the solution is extracted with an inert organic solvent that is not displaced with water, for example diethyl ether. After evaporation of the solvent from the extract, pure D-2-hydroxy-4-methyl mercapto-butyric acid is obtained, which crystallizes after a long standing in the cold. To obtain the sodium, potassium, magnesium, or calcium salt, the acid is dissolved in a very small amount of water and mixed with about an equivalent amount of the corresponding hydroxide, oxide, bicarbonate, or carbonate. The resulting salt solution after treatment with activated carbon is evaporated to dryness under reduced pressure, and get the pure D-form of the corresponding salt. 1 D -2-Hydroxy-4-methyl mercapl butic acid or a salt of this acid can be converted by a known method into the methyl ester 13 by exchange with methanol in the presence of a catalyst to form an ester, such as hydrochloric acid, sulfuric acid or toluenesulfonic acid. -2-hydroxy-4-methylmercaptobutyric acid. If a salt of D-2-hydroxy-4-methyl-mercryl-butyric acid is used for this reaction, it is necessary to use an excessive versus stoichiometric amount of (mineral) acid. The ester formation reaction is especially good if D-2-hydroxy-4-methyl mercapto-butyric acid and the salt are added at a lower temperature to the mixture of thionyl chloride and methanol. From this mixture, the ester is recovered in the usual way, absorbing it with water and extracting it with an organic solvent. D-2-hydroxy-4-methyl-mercapto-butyric acid methyl ester can be acylated to 2-acetoxy derivative by treatment with acetyl chloride or acetic anhydride, preferably in the presence of a tertiary amine, such as pyridine or 4-dimethylaminopyridine. Reaction
    it is permissible to hold B in the presence of ip absence of a diluent. Deposition of D-2-aietoxy-4-methyl-mercapto-butyric acid methyl ester is carried out in the usual way, by mixing with water and extracting with an organic solvent.
    The derivatives of 1) -2-hydroxy-4-methyl-mercaptobutyric acid, proposed above, in particular, their carbon salt, are suitable for use as an additive to methionine in simple and complex feed, food, for a balanced synthetic diet and for the manufacture of specialized pharmaceutical preparations with nutritional and anabolic substance.
    As a result of the manufacture of derivatives according to the proposed method, it is possible to enrich the complex feed with a significantly smaller amount of calcium salt of 2-hydroxy-4-methyl mercaptomass acid, since the D-form is more effective in terms of physiological nutritional properties than the known racemate. An additional advantage of using clean TK-forms is that the animal's organism is protected from a less effective L-form, which is equivalent to unloading the metabolic system.
    Derivation of derivatives according to the proposed invention is of interest in the production of foodstuffs, especially those based mainly on soybean protein. This is explained by the fact that soy protein, which in many countries of the world is the staple food, contains only a small amount of natural methionine. It follows that food, based mainly on soy proteins, can easily lead to inadequate supply of methionine and, as a consequence, to the phenomena of golodani.
    The proposed derivatives are also of great value for the preparation of balanced synthetic diets, for example, for providing astronauts with food. Naturally, in this case, first of all
    They mean superiority in terms of the physiology of nutrition, moreover, smell, taste and solubility are also of great importance, since cosmonauts
    parts use coziness food products in the form of an aqueous solution or paste. The proposed derivatives are coherent in taste and smell. In terms of solubility in water, they satisfy the existing requirements.
    The calcium salt of 1) -2-hydroxy-4-methyl mercaptoacid acid is of particular importance in the manufacture of drugs, especially special drugs for the treatment of patients with renal insufficiency. The meaning and purpose of this kind of kidney diets is the body's load with the least amount of nitrogen or ammonia-containing substances, since ammonia (in the form of urea) deprives ammonia and stops it is very difficult (noosmic kidney). On the other hand, various L-c-amino acids that are important to humans must be supplied with food products. Recent studies show that it is possible to replace at least one important amino acid of the corresponding ot-oxia / or oi-KSTO acids. These acids bind ammonia in the body, which is formed as a result of other metabolic processes and represents d for renal patients and neutralizes to a certain degree while simultaneously forming the necessary for o (amino acids.
    Until now, in the composition of renal dyes of this kind, instead of the important L-methionine, the recicemic calcium salt of D JL - -2 -oxy-4-methylated lymphocytes is used in almost all cases. Since in renal diseases the most benign regimen should be ensured in order to avoid additional stress on the kidneys, the more effective the racemate is to replace the racemate with a more efficient enantiomeric with respect to the physiology of nutrition;) - form. The percentages in all examples are expressed by weight percent unless specifically indicated.
    Example 1. 569.9 g (4 mol) of D-methionine are dissolved in 343 O g of 1 O% sulfuric acid and mixed at 0-5 C for 2 hours with an ice-cooled solution of 345 g (5 mol) of sodium nitrite in 5OO ml of water. It is left overnight so that the mixture is heated to 20-25 ° C, saturated with sodium chloride and then extracted with 460.0 ml of ether. After drying over sodium sulfate, the solvent is distilled off from the combined ether phase. An oily residue of 96.3 g (14.4% of the theoretical) of crude D-2-hydroxy-4-methyl-mercaptomacy acid is obtained.
    The residue is taken up in ether and mixed with dicyclohexylamine until it crystallizes out.
    no extra salt. The ammonia ammonium crystallized out is recrystallized several times from a mixture of ethyl acetate and petroleum ether. As a result, 100.2 g (52.4% of the theoretical) of dicyclohexipammonium salt of the purity category were obtained. but.
    Salt hydrolyzing 111 g of 40% sulfuric acid. After the sodium sulfate is added, the mushy salt mass is filtered and re-washed four times with ether. The combined filtrates are separated into organic and aqueous phases. The latter is additionally extracted three times with ether. Next, the combined ethereal solutions are dried over magnesium sulfate, filtered, and ground, and 42 g of 95% 1) -2-hydroxy-4-methyl mercaptobutyric acid are obtained. It has the following characteristics: melting point from (-1) to (5 ° C) and the following: e rotation p (., 9 ° (water).
    The acid is dissolved in 100 ml of water.
    and slurry with a suspension of 9.9 g of calcium hydroxide in 10 O ml of water. After treatment with activated carbon, the aqueous solution is evaporated to dryness in a vacuum created by a water-jet pump. 45.4 g (88% of theoretical) of calcium sulfate 13 -2-hydroxy-4-methylmercaptoacid acid, having proper rotation | oij25424.3 (O1; water).
    Example 2. 42 g of the 95% D-2-hydroxy-4-methymercapto-butyric acid obtained in Example 1 are dissolved in 100 ml of water and mixed with a suspension of 5.4 g of magnesium oxide in 100 ml of water. After treatment with activated carbon, the aqueous solution is evaporated to dryness in a vacuum created by a water-jet pump. 43.2 g (88% of theoretical) of the magnesium salt of D-2-hydroxy-4-methyl mercaptomaspric acid remain.
    . A and ivi er 3. 15.8 g of the 95% 0-2-hydroxy-4-methyl mercaptomass acid prepared in Example 1 is dissolved in 40 ml of water and mixed with 2Ohm 5N. sodium hydroxide solution. After treatment with activated carbon, the aqueous solution is evaporated to dryness in a vacuum created by a water-jet pump.
    15.0 g (87% of theoretical) of 1E-2-hydroxy-4-methyl-mercapto-acetic acid sodium salt remains.
    Example 4. 15.8 g of 95% K (J) -2-hydroxy-4-methyl mercaptomeric acid, prepared according to Example 1, are dissolved in 40 ml of water and mixed with 20 m 5 n. solution of hydrate oxide kagga. After treatment with activated carbon, the aqueous solution is evaporated to dryness in a vacuum created by a water-jet pump. 16.9 g (9O% of theoretical) potassium salt X) -2-hydroxy-4-methyl mercaptoacid acid remain.
    Example 5. 8.3 g (0, O7 mol) of thionyl chloride at -5 ° C are added to 20 ml of absottic methanol and stirred for 15 minutes.
    10.15 g (O, OZ mol) of the calcium salt of 1E-2-hydroxy-4-methymercapto-butyric acid obtained in example i is dissolved at boiling point in 25 ml of absolute methanol. The solution is added dropwise to the above described reaction mixture. The ether is then mixed with water and separated into organic and aqueous phases. After the second 3 more times extracted with ether. The combined ether phases are dried over sodium bicarbonate and sodium sulfate, filtered and evaporated. There remains 8.7 g (88.3% of theoretical) of methyl TD-2-hydroxy-4-methyl-mercaptomatic ester methyl ester.
    Example 6. 8.7 g (0.053 mol) of D-2-hydroxy-4-methyl-mercapto-butyric acid methyl ester obtained in Example 5 are dissolved in 30 ml of absolute ether and 4.19 (0.053 mol) of pyridine. When added dropwise with stirring, 4.16 g (0.053 mol) of acetyl chloride. After stirring overnight, the precipitated hydrochloride salt of pyridine is filtered off and re-washed with ether. The ether solution is washed once with 10 ml of 2N. sulfuric acid solution and 3 times with 10 ml portions of water, dried over magnesium sulphate and evaporated. 8.98 g (82.8% of theoretical) D-2-acetoxy-4-methyl-mercapto-butyric acid methyl ester remains.
    Example 7. In the experiment on feeding t-males, the effectiveness of the D-form of the calcium salt of 2-hydroxy-4-methymercapto-butyric acid was checked in comparison with the racemate, hence the D, U-form. In each test group, a half-purified basic ration based on soy protein is applied, to which a mixture of amino acids is added, excluding amino acids containing sulfur. This basic ration has the following composition, wt.%: Maize starch (granulated) 31.15; dextrose 25.00; soy flour (48.3% raw protein) 31, OO; a mixture of amino acids 5, OO; corn oil 2.50; celpose 1,00; two-calcium phosphate 2.20; SASOD 1, OO; sodium chloride 0,4O; sodium bicarbonate 0.50; suprapat manganese 0.05; zinc carbonate (100 h per mil); chlorine chloride 0.10; a mixture of vitamins 0.10. A mixture of amino acids, wt.%: L-arginine hydrochloride 0,29; L-histidine hydrochloride —NO O, 11; L-pizin hydrochloride 0,29; L-tyrosine 0.11; L-tryptophan 0, O4; L-phenylalanine O, 13; L-threonine ODB; L-leucine 0.25; L-isopeucine 0.15; L-wapine 0.17; 0.15; L-proline 0.10; B-glutamate 3.05 (total 5, OO). The cockerels of the first experimental group received only the specified basic ration depleted in respect of sulfur-containing amino acids; the lettuce of the second experimental group received an additional 0.16 Bes., Calculated on the basic ration of the calcium salt J). L-2-oxy-4-methylmercaptomethyl acid and pellicle of the third experimental group of Lupuchapn in addition to 0.16% by weight 0.16% by weight of B-2-hydroxy-4-methylmercaptomeric acid 35 The average test criteria was daily weight gain of one chicken, as well as the degree of feed utilization. Ved-form for where from the metat ate dt 40 40 equal results of the experiment are in the table. manual of derivatives of D-2- and-4-methy-percapto-butyric acid in IH CH, - 5-СЦ2. -CHa-CH-COOA C) R A - potassium, sodium, magnesium, calcium or methyl group; R is hydrogen or acetyl group, characterized in that D onin is subjected to treatment with nitric acid and the resulting 1) -2-hydroxy-4-percaptoacid transcription of the corresponding salt or methyl ester by treatment with methanol and / or is acetylated over a hydroxyl group. Sources of information taken into account during the examination 1. US Patent No. 3272860, cl. 260-535, published. 1966.
    权利要求:
    Claims (1)
    [1]
    where A is potassium, sodium, magnesium, calcium or methyl group;
    K - hydrogen or acetyl group, characterized in that p methionine is treated with nitrous acid and the resulting B — 2 — hydroxy — 4 — methyl mercaptomaspyanic acid is transferred to the corresponding salt or methyl ester by treating with methanol and / or acetylated over a hydroxyl group.
    Sources of information taken into account in the examination
    1. US Patent No. 3272860, cl. 260-53 5, published. 1966.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU895286A3|1981-12-30|Method of preparing derivatives of d-2-oxy-4-methylmercaptobutyric acid
    US3950372A|1976-04-13|1:1 Manganese alpha amino acid complexes
    JP2005517010A|2005-06-09|Astaxanthin ester
    SU1523043A3|1989-11-15|Method of feeding farm animals and poultry
    Westall1953|The amino acids and other ampholytes of urine. 2. The isolation of a new sulphur-containing amino acid from cat urine
    Barger et al.1918|Carnosine, constitution and synthesis
    US3015567A|1962-01-02|Process for enriching the l-lysine content of food and the resulting product
    BRPI0920882B1|2018-04-10|“Process for DL-methionyl-DL-methionine preparation and isolation of the DD / LL / DL / LD- methionyl methionine dialysis mixtures and their use”
    EP0377526A2|1990-07-11|Use of copper complexes of alpha-amino acids that contain terminal amino groups as nutritional supplements
    US3864362A|1975-02-04|Iso flavones
    US3351525A|1967-11-07|Coccidiostatic compositions and methods of using same
    CA2041818C|2003-02-11|Separation of enantiomers of cimaterol, |-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers
    IL45123A|1977-12-30|5-methyl-isoflavone-derivatives process for preparation thereof and pharmaceutical compositions containing them
    JPH10502382A|1998-03-03|Process for producing ammonium-2-hydroxy-4- | -butyrate, liquid mixture containing the same and use thereof
    PAUL et al.1961|Some side reactions of nitro-L-arginine
    US3715375A|1973-02-06|New diphenyl sulfones
    US4056658A|1977-11-01|Food and fodder additive
    JP2011501749A|2011-01-13|Method for producing carnosol from carnosic acid
    US6054585A|2000-04-25|Process for making high purity piperine for nutritional use
    Work et al.1955|Separation of the Three Isomeric Components of Synthetic α, ε-Diaminopimelic Acid1
    FI78815C|1989-10-10|Carbatzic acid derivatives for use in animal husbandry in livestock care
    EP3653633A1|2020-05-20|Methionine-metal chelate and production method thereof
    Hill et al.1936|A new synthesis of methionine and a scheme relating certain α-amino-acids
    US3850987A|1974-11-26|Compounds useful as feed supplements
    EP0124752B1|1986-07-16|Mixtures of substances with growth and output accelerating effect as well as feed and watering liquids which contain low amounts of these mixtures
    同族专利:
    公开号 | 公开日
    FR2450811B1|1984-04-20|
    DK94880A|1980-09-07|
    DE2945497A1|1980-10-09|
    BE882067A|1980-09-04|
    JPS55127359A|1980-10-02|
    FR2450811A1|1980-10-03|
    GB2044755A|1980-10-22|
    NL7908887A|1980-09-09|
    DE2945497C2|1990-04-19|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    BE611435A|1960-12-14|1962-06-12|Stamicarbon|Process for the preparation of metal salts of alpha-hydroxy-gamma -methylmercaptobutyric acid|
    DE2516027A1|1973-04-30|1975-10-16|Univ Johns Hopkins|Compsns for promoting protein synthesis and nitrogen conservation|US4335257A|1980-09-05|1982-06-15|E. I. Du Pont De Nemours And Company|Preparation of the calcium salt of alpha-hydroxy-gamma-methylmercaptobutyric acid|
    US4513005A|1981-06-18|1985-04-23|Lilly Industries Limited|SRS-A antagonists|
    US4782173A|1983-08-03|1988-11-01|The Standard Oil Company|Synthesis of methionine hydroxy analog or derivative, and esters thereof; synthesis of 1-acyloxy-4-hydrocarbylthiopropene, and products|
    DE3462792D1|1983-09-06|1987-04-30|Monsanto Co|Enhanced 2-hydroxy-4-methylthiobutanoic acid composition and method of preparation|
    JPH0469144B2|1984-02-13|1992-11-05|Ajinomoto Kk|
    MY109603A|1992-05-21|1997-03-31|Daicel Chem|Process for producing 2-hydroxy-4-methylthiobutanoic acid|
    IT1310947B1|1999-03-05|2002-02-27|Agristudio Srl|FOOD SUPPLEMENT CHELATED FOR AGRO-ZOOTECHNICAL USE, AND METHOD FOR OBTAINING THE SAME.|
    FR2791673B1|1999-04-02|2001-06-08|Rhone Poulenc Animal Nutrition|PROCESS FOR THE PREPARATION OF ESTERS OF HYDROXYMETHYLTHIOBUTYRIC ACID|
    WO2001058864A1|2000-02-07|2001-08-16|Rhone-Poulenc Animal Nutrition|Process for the preparation of 2-hydroxy-4-methylthio butyric acid esters|
    CN101287805B|2005-09-06|2011-11-02|诺华丝国际股份有限公司|Marine antifouling coating compositions|
    FR2907785B1|2006-10-27|2009-01-16|Tetrahedron Sas|PROCESS FOR THE PREPARATION OF 2-HYDROXY-4-METHYLSELENOBUTYRIC ACID, ALONE OR IN MIXTURE WITH ITS SULFUR ANALOGUE, AND THEIR USES IN NUTRITION, ESPECIALLY ANIMAL NUTRITION|
    CN103254104B|2013-05-24|2015-06-24|长沙兴嘉生物工程股份有限公司|Preparation method of microelement methionine hydroxy analogue chelate additive|
    CN104341329A|2014-10-20|2015-02-11|高纪峰|Production method of calcium 2-hydroxy-4-butyrate|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US1835979A| true| 1979-03-06|1979-03-06|
    [返回顶部]